Annual Report 2022-2023
Annual Report 2021-2022
Annual Report 2020 – 2021
Annual Report 2019 – 2020
Annual Report 2018 – 2019
Annual Report 2017 – 2018
Annual Report 2016 – 2017
Annual Report 2015 – 2016
Annual Report 2014 – 2015
Annual Report 2013 – 2014
Annual Report 2012 – 2013
Annual Report 2011 – 2012
Annual Report 2010 – 2011
Annual Report 2009 – 2010
Annual Report 2008 – 2009
Annual Report 2007 – 2008
Annual Report 2006 – 2007
Live Share Price
Historical Share Performance
Half Year ended 31st March, 2023
Half Year ended 30th September, 2022
Half Year ended 31st March, 2022
Half year ended 30th September, 2021
Half year ended 31st March, 2021
Half Year ended 30th September, 2020
Half Year ended 31st March, 2020
Board Meeting – 14.08.2023
Board Meeting – 19.07.2023
Board Meeting – 23.05.2023
Board Meeting -24.01.2023
Board Meeting – 14.11.2022
Board Meeting – 27.10.2022 (Buyback)
Board Meeting – 08.08.2022 (Dividend Intimation)
Board Meeting – 08.08.2022
Board Meeting – 23.05.2022
Board Meeting – 11.02.2022
Board Meeting – 12.11.2021
Board Meeting – 25.08.2021
Board Meeting – 13.08.2021
Board Meeting – 29.05.2021
Board Meeting – 09.02.2021
Board Meeting – 10.11.2020
Board Meeting – 13.08.2020
Board Meeting – 30.05.2020
Board Meeting – 05.02.2020
Board Meeting – 13.11.2019
Board Meeting – 24.09.2019
Board Meeting – 13.08.2019
Board Meeting – 27.05.2019
Board Meeting – 14.02.2019
Board Meeting – 20.12.2018
Board Meeting – 14.11.2018
Board Meeting – 09.08.2018
Board Meeting – 24.05.2018
Board Meeting – 07.02.2018
Board Meeting – 27.10.2017
Board Meeting – 08.08.2017
Board Meeting – 24.05.2017
Board Meeting – 27.03.2017
Board Meeting – 31.01.2017
Board Meeting – 09.01.2017
Board Meeting – 13.12.2016
Board Meeting – 14.09.2016
Board Meeting – 10.05.2016
Board Meeting – 04.02.2016
Board Meeting – 13.11.2015
Board Meeting – 26.05.2015
Board Meeting – 13.08.2014
Historical Financials
<span data-mce-type="bookmark" style="display: inline-block; width: 0px; overflow: hidden; line-height: 0;" class="mce_SELRES_start"></span>
UPL’s acquisition of Arysta LifeScience has received regulatory approval worldwide and together we are moving fast to creating a new leader in global agriculture.
Our websites will continue to be the best place to get news updates over the next months as we fully integrate our combined businesses.
Thank You.
